Is It Worth Treating Non-Bothering Nocturia? Results of a Multicenter Prospective Observational Study

Kwangsung PARK; Hyoung-Keun PARK; Sae-Woong KIM; Dae-Yul YANG; Jong-Kwan PARK; Hyun-Jun PARK; Ki-Hak MOON; Du-Geon MOON; Kweon-Sik MIN; Hwancheol SON; Sung-Won LEE; Jae-Seog HYUN; Woo-Suk CHOI; Sang-Kuk YANG.
The World Journal of Men's Health ; : 248-254, 2018.
Artículo en Inglés | WPRIM | ID: wpr-716911

Documentos relacionados

  1. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
  2. Comparison of IPSS score and voiding parameters in men presenting with LUTS.
  3. Re: The Change of IPSS 7 (Nocturia) Score Has the Maximum Influence on the Change of Qol Score in Patients with Lower Urinary Tract Symptoms.
  4. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network meta-analysis.
  5. Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study.
  6. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
  7. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting.
  8. Differences in surgical and functional outcomes in benign prostate hyperplasia patients with only lower urinary tract symptoms versus those in retention: A systematic review and meta-analysis.
  9. Re: The Change of IPSS 7 (Nocturia) Score Has the Maximum Influence on the Change of Qol Score in Patients with Lower Urinary Tract Symptoms.
  10. Effect of Prostate Artery Embolization on Erectile Function - A Single Center Experience of 167 Patients.